Herbl’s high hopes run out of green
For the majority of the past five years, Goleta-based Herbl was shipping a lot of cannabis and making a lot of green in the process, reporting that sales exceeded $200 million in 2022. But as of August 2023, the company has largely ceased operations and filed for receivership. Once the largest cannabis distributor in the Read More →
Olaplex fails to meet expectations again, lowers guidance
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen gives confidence to investors on pending purchase
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
MannKind excites investors, analysts after huge bump in sales
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Mercado: Region’s AI scene highlights diversity among tech companies
A lot of the focus on the technology scene along the Central Coast this year has been on biotechnology — and rightfully so given the sprawl we are seeing pop up in the Conejo Valley. But something that isn’t quite so obvious on the surface is the amount of artificial intelligence you could find up Read More →
AI companies in the tri-county region see sizeable backing
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen CEO leads tri-county public company executives
Bob Bradway, Amgen’s CEO since May of 2012, raked in the most of any executive of a public company based on the Central Coast in 2022, generating a total compensation worth $21.4 million, according to a Business Times study. According to filings with the U.S. Securities and Exchange Commission, Bradway pulled in a base salary Read More →
